Michelle Robertson

Chief Financial Officer

CFO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Editas Medicine, Inc. (EDIT)	Former Executive Vice President and Chief Financial Officer	$303,464	—	$274,680	$823,799	—	$175,553	$1,577,496
2022	Editas Medicine, Inc. (EDIT)	Former Executive Vice President and Chief Financial Officer	$450,915	—	$924,998	$1,849,343	$189,540	$7,290	$3,422,086
2021	Editas Medicine, Inc. (EDIT)	Former Executive Vice President and Chief Financial Officer	$415,754	—	$627,408	$977,865	$218,700	$7,290	$2,247,017

Earnings-call appearances

Editas Medicine, Inc. Q1 FY2023 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-05-05
Editas Medicine, Inc. Q4 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2023-02-22
Editas Medicine, Inc. Q3 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-11-02
Editas Medicine, Inc. Q2 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-08-03
Editas Medicine, Inc. Q1 FY2022 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-05-04
Editas Medicine, Inc. Q4 FY2021 Earnings Call
Editas Medicine, Inc. (EDIT)

2022-02-24
Editas Medicine, Inc. Q3 FY2021 Earnings Call
Editas Medicine, Inc. (EDIT)

2021-11-08
Editas Medicine, Inc. Q2 FY2021 Earnings Call
Editas Medicine, Inc. (EDIT)

2021-08-04
Editas Medicine, Inc. Q1 FY2021 Earnings Call
Editas Medicine, Inc. (EDIT)

2021-05-05
Editas Medicine, Inc. Q4 FY2020 Earnings Call
Editas Medicine, Inc. (EDIT)

2021-01-19
Editas Medicine, Inc. Q3 FY2020 Earnings Call
Editas Medicine, Inc. (EDIT)

2020-11-05
Editas Medicine, Inc. Q2 FY2020 Earnings Call
Editas Medicine, Inc. (EDIT)

2020-08-06
Editas Medicine, Inc. Q1 FY2020 Earnings Call
Editas Medicine, Inc. (EDIT)

2020-05-07